RespireRx Pharmaceuticals Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
RespireRx Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2023.
  • RespireRx Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2023 was 14.8 %, a 37.8% decline year-over-year.
  • RespireRx Pharmaceuticals Inc. annual Return On Equity for 2022 was 18.5 %, a 46% decline from 2021.
  • RespireRx Pharmaceuticals Inc. annual Return On Equity for 2021 was 34.3 %, a 38.9% decline from 2020.
  • RespireRx Pharmaceuticals Inc. annual Return On Equity for 2020 was 56.1 %, a 81.3% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 14.8 -8.96 -37.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 15.6 -11.6 -42.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 14.3 -18 -55.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 18.5 -15.8 -46% Oct 1, 2022 Dec 31, 2022
Q3 2022 23.7 -15.7 -39.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 27.3 -24.3 -47.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 32.3 -20.9 -39.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 34.3 -21.9 -38.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 39.5 -12.1 -23.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 51.5 +13.1 +34.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 53.1 +17.8 +50.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 56.1 +25.2 +81.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 51.5 +17.8 +52.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 38.4 +1.2 +3.22% Apr 1, 2020 Jun 30, 2020
Q1 2020 35.3 -7.29 -17.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 31 -18.1 -36.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 33.8 -17.6 -34.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 37.2 -12.3 -24.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 42.6 -21.1 -33.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 49 -24.5 -33.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 51.4 -31.9 -38.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 49.5 -72.3 -59.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 63.7 -97.1 -60.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 73.5 -134 -64.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 83.3 -168 -66.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 122 -180 -59.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 161 -119 -42.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 207 -27.8 -11.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 251 +40.6 +19.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 302 +161 +114% Apr 1, 2016 Jun 30, 2016
Q1 2016 280 +190 +212% Jan 1, 2016 Mar 31, 2016
Q4 2015 235 +115 +95.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 210 +136 +183% Jul 1, 2015 Sep 30, 2015
Q2 2015 141 +94.8 +204% Apr 1, 2015 Jun 30, 2015
Q1 2015 89.7 +42.4 +89.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 120 +90.4 +304% Oct 1, 2014 Dec 31, 2014
Q3 2014 74.4 -59.3 -44.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 46.4 -221 -82.7% Apr 1, 2014 Jun 30, 2014
Q1 2014 47.3 -379 -88.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 29.8 -854 -96.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 134 +4.88K Jul 1, 2013 Sep 30, 2013
Q2 2013 268 -439 -62.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 426 +2.45K Jan 1, 2013 Mar 31, 2013
Q4 2012 884 Oct 1, 2012 Dec 31, 2012
Q3 2012 -4.75K Jul 1, 2012 Sep 30, 2012
Q2 2012 707 Apr 1, 2012 Jun 30, 2012
Q1 2012 -2.02K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.